Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation
The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212 · cited 1×
“HIF-1 is a heterodimer consisting of the subunits HIF-1a and HIF-1b, both belonging to the basic-helix-loop-helix Per-aryl hydrocarbon receptor nuclear translocator-Sim (PAS) family of transcription factors [47].”
BackgroundThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180 · cited 2×
“VHL appears to target HIF-1 for proteolysis, since constitutive HIF-1a stabilisation and activation were detected in VHL mutant cells [55].”
BackgroundVascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617 · cited 2×
“Its expression is increased during exposure to hypoxia and mRNA levels return to background levels during re-oxygenation in vitro [33].”
BackgroundRole of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300 · cited 1×
“Hypoxia-induced apoptosis was found to be reduced in cells lacking p53, and small numbers of cells lacking p53 could outgrow similar p53 wild-type cells under hypoxia in vitro [72].”
BackgroundPlate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,275
(1999) · PubMed · Cited by 2,204
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Höckel, M., Schlenger, K., Aral, B., Mitze, M., Schäffer, U., & Vaupel, P. W. (1996) · PubMed · Cited by 1,926
General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia.
Wang, G. L., & Semenza, G. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.4304 · Cited by 1,468
Cited by
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662
Vascular Endothelial Growth Factor and Angiogenesis
Hoeben, A., Landuyt, B., Highley, M. S., Wildiers, H., Van Oosterom, A. T., & De Bruijn, E. A. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.4.3 · Cited by 1,824
“Some authors have postulated that HIF-1 itself, as an iron-containing protein, can perform this function, whereas others have suggested that a NAPDH-linked oxidase is involved (Forsythe et al., 1996; Ryan et al., 1998; Srinivas et al., 1998; Dachs and Tozer, 2000; Richard et al., 2000; Tsuzuki et al., 2000).”
BackgroundInfluentialMichiels, C. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10333 · Cited by 773
Metastasis: recent discoveries and novel treatment strategies
Eccles, S. A., & Welch, D. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60781-8 · Cited by 721
Physiological and pathological responses to hypoxia
Michiels, C. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63747-9 · Cited by 559
“Various signals that trigger this switch have been identified, including immune/inflammatory response and genetic mutations, but metabolic stress (hypoxia) is probably the most important one.(48,49) Tumor cells survive fluctuations in oxygen tension through activation of hypoxia-inducible factor-1.”
BackgroundTumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies
Shannon, A. M., Bouchier-Hayes, D. J., Condron, C. M., & Toomey, D. (2003) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(03)00003-3 · Cited by 559
Treatment Resistance of Solid Tumors
Vaupel, P., Thews, O., & Hoeckel, M. (2001) · Medical Oncology · doi:10.1385/mo:18:4:243 · Cited by 558
Cooke, V. G., LeBleu, V. S., Keskin, D., Khan, Z., O'Connell, J. T., Teng, Y., Duncan, M. B., Xie, L., Maeda, G., Vong, S., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.11.024 · Cited by 530
Nitric oxide, a double edged sword in cancer biology: Searching for therapeutic opportunities
Mocellin, S., Bronte, V., & Nitti, D. (2007) · Medicinal Research Reviews · doi:10.1002/med.20092 · Cited by 478
YC-1: A Potential Anticancer Drug Targeting Hypoxia-Inducible Factor 1
Yeo, E.-J., Chun, Y.-S., Cho, Y.-S., Kim, J., Lee, J.-C., Kim, M.-S., & Park, J.-W. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.7.516 · Cited by 476
Tumor Hypoxia Has Independent Predictor Impact Only in Patients With Node-Negative Cervix Cancer
Fyles, A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.3.680 · Cited by 397
RNA modifications regulating cell fate in cancer
Delaunay, S., & Frye, M. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0319-0 · Cited by 365
(2002) · PubMed · Cited by 349
Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1
Ridnour, L. A., Isenberg, J. S., Espey, M. G., Thomas, D. D., Roberts, D. D., & Wink, D. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502979102 · Cited by 323
Hypoxia Positron Emission Tomography Imaging With 18F-Fluoromisonidazole
Lee, S. T., & Scott, A. M. (2007) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2007.07.001 · Cited by 283
Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy
Zahra, M. A., Hollingsworth, K. G., Sala, E., Lomas, D. J., & Tan, L. T. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(06)71012-9 · Cited by 272
MATEO, J., GARCÍA-LECEA, M., CADENAS, S., HERNÁNDEZ, C., & MONCADA, S. (2003) · Biochemical Journal · doi:10.1042/bj20031155 · Cited by 258
Welsh, S., Williams, R., Kirkpatrick, L., Paine-Murrieta, G., & Powis, G. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.233.3.3 · Cited by 240
Nordsmark, M., Alsner, J., Keller, J., Nielsen, O. S., Jensen, O. M., Horsman, M. R., & Overgaard, J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1728 · Cited by 226
“In-v studies have provided interesting results and shown that normal and cancer cells alter gene expression under hy conditions (Sutherland, 1996, Dachs and Tozer, 2000), suppo the role of hypoxia in malignant progression.”
BackgroundEffects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes
Lolmède, K., Durand de Saint Front, V, Galitzky, J., Lafontan, M., & Bouloumié, A. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802407 · Cited by 224
Potential Mechanisms of Action for Vitamin C in Cancer: Reviewing the Evidence
Vissers, M. C. M., & Das, A. B. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00809 · Cited by 188
Martinive, P., Defresne, F., Bouzin, C., Saliez, J., Lair, F., Grégoire, V., Michiels, C., Dessy, C., & Feron, O. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2056 · Cited by 190
“Transcriptomic studies are ongoing in our laboratory to identify downstream targets within the many genes with hypoxia-responsive elements containing promoters (42).”
BackgroundPromoters and Control Elements: Designing Expression Cassettes for Gene Therapy
Papadakis, E., Nicklin, S., Baker, A., & White, S. (2004) · Current Gene Therapy · doi:10.2174/1566523044578077 · Cited by 170
Stimulation of angiogenesis by Ras proteins
Kranenburg, O., Gebbink, M. F. B. G., & Voest, E. E. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2003.09.004 · Cited by 168
Oxygenation in Cell Culture: Critical Parameters for Reproducibility Are Routinely Not Reported
Al-Ani, A., Toms, D., Kondro, D., Thundathil, J., Yu, Y., & Ungrin, M. (2018) · PLOS ONE · doi:10.1371/journal.pone.0204269 · Cited by 152
Modulation of hypoxia-inducible factor-1 alpha in cultured primary cells by intracellular ascorbate
Vissers, M. C. M., Gunningham, S. P., Morrison, M. J., Dachs, G. U., & Currie, M. J. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.11.023 · Cited by 125
Self-citation
Metadata
- Authors
- Dachs, G. U., & Tozer, G. M.
- Venue
- European Journal of Cancer
- Publisher
- Elsevier BV
- Published
- 2000-08
- Volume
- 36
- Issue
- 13
- Pages
- 1649-1660
- ISSN
- 0959-8049 (ISSN-L)
- OpenAlex
- W1971849102
- Cited by
- 272
- References
- 134
- FWCI
- 9.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.